ATE209034T1 - Taxolderivate - Google Patents

Taxolderivate

Info

Publication number
ATE209034T1
ATE209034T1 AT94921511T AT94921511T ATE209034T1 AT E209034 T1 ATE209034 T1 AT E209034T1 AT 94921511 T AT94921511 T AT 94921511T AT 94921511 T AT94921511 T AT 94921511T AT E209034 T1 ATE209034 T1 AT E209034T1
Authority
AT
Austria
Prior art keywords
taxol derivatives
formula
taxol
ch2opo3
ch2oso3
Prior art date
Application number
AT94921511T
Other languages
English (en)
Inventor
Larry L Klein
Clarence J Maring
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE209034T1 publication Critical patent/ATE209034T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
AT94921511T 1993-07-15 1994-07-15 Taxolderivate ATE209034T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/092,124 US5468769A (en) 1993-07-15 1993-07-15 Paclitaxel derivatives
PCT/US1994/007973 WO1995002400A1 (en) 1993-07-15 1994-07-15 Taxol derivatives

Publications (1)

Publication Number Publication Date
ATE209034T1 true ATE209034T1 (de) 2001-12-15

Family

ID=22231738

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94921511T ATE209034T1 (de) 1993-07-15 1994-07-15 Taxolderivate

Country Status (8)

Country Link
US (1) US5468769A (de)
EP (1) EP0708642B1 (de)
JP (1) JPH09500138A (de)
AT (1) ATE209034T1 (de)
CA (1) CA2165079A1 (de)
DE (1) DE69429173T2 (de)
ES (1) ES2168304T3 (de)
WO (1) WO1995002400A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990325A (en) 1993-03-05 1999-11-23 Florida State University Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof
US5973160A (en) 1992-12-23 1999-10-26 Poss; Michael A. Methods for the preparation of novel sidechain-bearing taxanes
DE69403966T3 (de) 1993-07-19 2008-04-17 Angiotech Pharmaceuticals, Inc., Vancouver Anti-angiogene mittel und verfahren zu deren verwendung
US5965566A (en) * 1993-10-20 1999-10-12 Enzon, Inc. High molecular weight polymer-based prodrugs
US6441025B2 (en) * 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
PL189698B1 (pl) 1996-03-12 2005-09-30 Pg Txl Co Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
AU4768797A (en) 1996-10-24 1998-05-15 Institute Armand-Frappier A family of canadensol taxanes, the semi-synthetic preparation and therapeutic use thereof
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20020077290A1 (en) * 2000-03-17 2002-06-20 Rama Bhatt Polyglutamic acid-camptothecin conjugates and methods of preparation
JP2004525860A (ja) 2000-09-22 2004-08-26 ブリストル−マイヤーズ スクイブ カンパニー 併用化学療法剤の毒性を低下させる方法
JP2004512381A (ja) 2000-11-02 2004-04-22 スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ Hsp90インヒビターの使用により細胞毒性剤の効力を増強させる方法
AU2003273671A1 (en) * 2002-10-09 2004-05-04 Phytogen Life Sciences, Inc. Novel taxanes and methods related to use and preparation thereof
WO2004089294A2 (en) 2003-04-04 2004-10-21 Incyte Corporation Compositions, methods and kits relating to her-2 cleavage
US7202370B2 (en) * 2003-10-27 2007-04-10 Conor Medsystems, Inc. Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
USH2260H1 (en) 2005-02-17 2011-07-05 Angiotech International Ag Stents combined with paclitaxel derivatives
CN101611007A (zh) 2006-12-20 2009-12-23 先灵公司 新颖的jnk抑制剂
CA2774769A1 (en) 2009-09-30 2011-04-07 Schering Corporation Novel compounds that are erk inhibitors
AU2011293612B2 (en) 2010-08-23 2015-11-26 Syntrix Biosystems Inc. Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulators
US8969365B2 (en) 2013-08-02 2015-03-03 Syntrix Biosystems, Inc. Thiopyrimidinecarboxamides as CXCR1/2 modulators
US10561676B2 (en) 2013-08-02 2020-02-18 Syntrix Biosystems Inc. Method for treating cancer using dual antagonists of CXCR1 and CXCR2
EP3027627B1 (de) 2013-08-02 2018-01-31 Syntrix Biosystems Inc. 2-[5-[n-(4-fluorophenyl)carbamoyl]pyrimidin-2-ylsulfanylmethyl]-4-(trifluoromethoxy)phenyl]bor saure
US10046002B2 (en) 2013-08-02 2018-08-14 Syntrix Biosystems Inc. Method for treating cancer using chemokine antagonists
US20220381786A1 (en) 2019-09-19 2022-12-01 Leap Therapeutics, Inc. Use of dkk-1 inhibitors for treating cancer
KR20220131223A (ko) 2019-11-22 2022-09-27 리프 테라퓨틱스 인코포레이티드 Dkk-1 억제제를 사용하여 암을 치료하는 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4942184A (en) * 1988-03-07 1990-07-17 The United States Of America As Represented By The Department Of Health And Human Services Water soluble, antineoplastic derivatives of taxol
WO1993021173A1 (en) * 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives

Also Published As

Publication number Publication date
DE69429173D1 (en) 2002-01-03
EP0708642A4 (de) 1996-03-12
US5468769A (en) 1995-11-21
ES2168304T3 (es) 2002-06-16
EP0708642A1 (de) 1996-05-01
JPH09500138A (ja) 1997-01-07
WO1995002400A1 (en) 1995-01-26
DE69429173T2 (de) 2002-07-04
CA2165079A1 (en) 1995-01-26
EP0708642B1 (de) 2001-11-21

Similar Documents

Publication Publication Date Title
ES2168304T3 (es) Derivados del taxol.
AU1608692A (en) Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
RU2088589C1 (en) Derivatives of 17 beta-substituted-4-aza-5-5 alpha-androstane-3-ones, methods of synthesis of compounds, pharmaceutical composition, compound 4
SE9203825L (sv) Dubbelt verkande inhibitorer foer no-syntas och cyklooxygenas, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
MX9302214A (es) Derivados de taxol y proceso para su preparacion
MX9204029A (es) Procedimiento de preparacion de un derivado de la bacatina iii y de la 10-desacetil bacatina iii
HUT61555A (en) Process for producing 2,8-dioxa-bicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same
DE69213546D1 (de) Neue Peptid-Verbindungen und Verfahren zur Herstellung davon
FI935800A0 (fi) Antidepressiva och mot Parkisons sjukdom verksamma foereningar
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
ATE344230T1 (de) Triphenylbutenderivate zur behandlung von neurologischen störungen
DE69330601D1 (de) Serotoninergische ergolin derivate
IL108665A (en) Pharmaceutical compositions containing ureido derivatives of substituted pyrroles, certain such novel compounds and their preparation
CA2030732A1 (fr) Nouveaux derives du thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant
HUT70761A (en) Alkyl derivatives of trazodone having action for central nervous system, pharmaceutical compositions for preparing thereof
SE8304410L (sv) Cyklohexylkarboxylsyraderivat och sett for deras framstellning
ATE149159T1 (de) Heteroarylmethylbenzole-aromatasehemmer
HUT39147A (en) Process for preparing phenoxy-propanol-acethylene derivatives and pharmaceutical compositions containing such compounds
AU577159B2 (en) Morpholinoethylamino-1,3,4-thiadiazole compounds
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
ATE100463T1 (de) Renin-hemmende aminooligohydroxy-derivate.
HUT68958A (en) Arylidene-1-azacycloalkane and aryl-alkyl-1-azacycloalkane derivatives their salts, pharmaceutical compositions containing them, and their preparation
ES8201993A1 (es) Un procedimiento para la preparacion de tiazoles
ES528459A0 (es) Procedimiento de preparacion de nuevos derivados 1-hidroxipropil resorcinos provistos de un grupo fenilo sustituidos.
SE8903313L (sv) Nya 2-metoxikarbonyl-substituerade n,n'-di-(trimetoxibensoyl)-piperaziner, foerfarande foer framstaellning daerav och terapeutiska foereningar innehaallande dem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee